Mainz Biomed N.V. announced a partnership with Labor MVZ Dr. Stein + Kollegen. Laboratory Mönchengladbach, will commercialize ColoAlert, Mainz Biomed's unique, highly efficacious, and easy-to-use detection test for colorectal cancer (CRC). With a team of over 500 employees that includes biologists, chemists, doctors and other specialists, Laboratory Mönchengladbach services over 2,500 physicians, processing over five million samples in total annually and screening approximately 1,000 patients per week specifically for CRC.

Under the terms of the partnership, Mainz Biomed will co-brand ColoAlert with Laboratory Mönchengladbach, and sell its polymerase chain reaction (PCR) assay kits for advanced colorectal cancer detection, on an on-demand basis for use by Labor Mönchengladbach's network of physicians and their patients. In order to optimize awareness and adoption, Mainz Biomed and Labor Mönchengladbach will also collaborate to deliver a comprehensive marketing and education campaign to include direct-to-consumer advertising, cross channel promotion to physician networks, webinars and sales representative training.